Mikra Serenity GCMS Verified Dietary Supplement for the Relief of Anxiety
Mikra Receives First Shipment of Serenity, an Innovative Mental Health Product for Anxiety, in Time for Black Friday
November 22, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Nov. 22, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Helping Children and
Helping Children and Adolescents with Emotional Problems: Free Webinar for Parents and Educators from the Brain & Behavior Research Foundation
November 16, 2023 13:00 ET | Brain & Behavior Research Foundation
New York, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Children’s mental health is a major concern and improving the potential for early intervention is essential. The Brain & Behavior Research Foundation...
Lifeist.png
Mikra Introduces Serenity, an Innovative Mental Health Product for Anxiety, Available for Purchase on Black Friday
November 16, 2023 07:00 ET | Lifeist Wellness Inc.
Serenity, a natural supplement based on the proven extract of lavender oil, will be available for sale on Black Friday (November 23, 2023) at weareMikra.com TORONTO, Nov. 16, 2023 (GLOBE NEWSWIRE)...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
November 13, 2023 16:15 ET | Cingulate Inc.
Phase 3 Adult Efficacy and Safety Trial Data Presented at Psych Congress Cingulate Closed a $4M Public Offering $5.8M of Debt Converted into CING Equity KANSAS CITY, Kan., Nov. 13, 2023 (GLOBE...
Lifeist.png
Lifeist's Mikra Completes Formulation of Innovative Mental Health Product for Anxiety 
November 02, 2023 07:00 ET | Lifeist Wellness Inc.
Mikra introduces Serenity, a new innovative product based on an extract of lavender oil aimed at supporting mental health
Cingulate_Logo_400x400_twitter.jpg
Cingulate to Host CNS Key Opinion Leader Panel in New York City
October 17, 2023 14:22 ET | Cingulate Inc.
KANSAS CITY, Kan., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
MDbio_Logo.png
Groundbreaking Study Finds Natural Formulation by MDbio – The Doctors BrandTM Significantly Improves Sleep, Anxiety, Stress, and Overall Well-being
October 03, 2023 09:00 ET | MDbio
Los Angeles, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- In a momentous large-scale clinical trial, a MDSleep formulation by MDbio – The Doctors BrandTM was proven to significantly improve sleep compared...
Lifeist.png
Lifeist's Mikra Introduces Innovative New Mental Health Product and Provides Corporate Update
September 26, 2023 07:00 ET | Lifeist Wellness Inc.
TORONTO, Sept. 26, 2023 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in...
Cingulate_Logo_400x400_twitter.jpg
Cingulate Inc. to Present at the LD Micro Main Event XVI
September 21, 2023 13:30 ET | Cingulate Inc.
KANSAS CITY, Kan., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ:CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform...
logo.png
Silo Pharma Announces Positive Data on SPC-15 for PTSD and Prepares to File Pre-Investigational New Drug (IND) Application with FDA
September 20, 2023 08:28 ET | Silo Pharma, Inc.
Pre-IND submission to FDA targeted for first quarter 2024 Silo partners with Kymanox for SPC-15 ENGLEWOOD CLIFFS, NJ, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq:...